Rahul Sarugaser
Stock Analyst at Raymond James
(0.01)
# 4,614
Out of 5,008 analysts
10
Total ratings
12.5%
Success rate
-27.99%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Rahul Sarugaser
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ONCY Oncolytics Biotech | Initiates: Outperform | $3 | $1.30 | +131.66% | 1 | Apr 4, 2024 | |
| QIPT Quipt Home Medical | Downgrades: Market Perform | $10 | $2.58 | +288.35% | 1 | Feb 16, 2024 | |
| DNA Ginkgo Bioworks Holdings | Downgrades: Market Perform | $100 | $16.28 | +514.25% | 4 | Nov 15, 2023 | |
| PROF Profound Medical | Downgrades: Outperform | n/a | $6.45 | - | 2 | Aug 4, 2023 | |
| VFF Village Farms International | Downgrades: Market Perform | $11 → $2.5 | $3.67 | -31.88% | 2 | Feb 27, 2023 |
Oncolytics Biotech
Apr 4, 2024
Initiates: Outperform
Price Target: $3
Current: $1.30
Upside: +131.66%
Quipt Home Medical
Feb 16, 2024
Downgrades: Market Perform
Price Target: $10
Current: $2.58
Upside: +288.35%
Ginkgo Bioworks Holdings
Nov 15, 2023
Downgrades: Market Perform
Price Target: $100
Current: $16.28
Upside: +514.25%
Profound Medical
Aug 4, 2023
Downgrades: Outperform
Price Target: n/a
Current: $6.45
Upside: -
Village Farms International
Feb 27, 2023
Downgrades: Market Perform
Price Target: $11 → $2.5
Current: $3.67
Upside: -31.88%